Tracking tumor kinetics in patients with germline CYLD mutations - 15/10/18
Doi : 10.1016/j.jaad.2018.04.014
Sarah Brown, MBBS a, Sylvia A. Worthy, MBBS b, James A.A. Langtry, MBBS a, Neil Rajan, MBBS, PhD a, c, ⁎ 
a Department of Dermatology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
b Department of Radiology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
c Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
∗Reprint requests: Neil Rajan, MBBS, PhD, Institute of Genetic Medicine, University of Newcastle upon Tyne, NE1 3BZ, United KingdomInstitute of Genetic MedicineUniversity of Newcastle upon TyneNE1 3BZUnited Kingdom
| Funding sources: Dr Rajan is a Wellcome Trust–funded intermediate clinical fellow (WT097163MA). |
|
| Conflict of interest: None disclosed. |
|
| Presented at the 95th Annual Meeting of the British Association of Dermatologists, Manchester, UK; July 7-9, 2015. |
© 2018
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 79 - N° 5
P. 949-951 - novembre 2018 Retour au numéro
Article précédent
- Cytokine levels in persistent skin lesions of adult-onset Still disease
- Elina Zuelgaray, Maxime Battistella, Marie-Dominique Vignon-Pennamen, Sophie Ly Ka So, Michel Rybojad, Antoine Petit, Florence Cordoliani, David Boccara, Maurice Mimoun, Dan Lipsker, François Chasset, Armand Bensussan, Martine Bagot, Jean-David Bouaziz, Laurence Michel, Study Group of Systemic Diseases in Dermatology (EMSED: Etude des Maladies Systémiques en Dermatologie)
- Bringing big data from social media reviews to quality improvement
- Severine Cao, Gideon P. Smith
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?